In fact, multiple studies have demonstrated that pharmacological activation of PPARδ by specific ligands can improve cardiac hypertrophy in cellular and animal models through mechanisms not yet fully elucidated [13,29,30,31]. This evidence concerns the gene PPARD and cardiac hypertrophy.